Electrical Stimulation for Erector Spinae Plane Catheter Insertion
Launched by STANFORD UNIVERSITY · Dec 8, 2022
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new method to help manage pain after shoulder surgery, specifically looking at a technique called the erector spinae plane (ESP) block. The researchers want to see if using electrical stimulation (a technique that helps find the best spot for the catheter) along with ultrasound guidance can improve the placement of the ESP catheter, which delivers pain relief medication. This study aims to enhance the effectiveness of pain control after surgery and to understand how often patients might experience certain nerve-related sensations during the procedure.
To participate in this trial, individuals must be scheduled for elective total or total reverse shoulder arthroplasty, which is a type of shoulder surgery. However, people who have a history of using opioids, those undergoing emergency procedures, or individuals with certain medical devices like pacemakers will not be eligible. If you join the study, you can expect to receive careful monitoring during the catheter placement procedure, and the researchers will track your pain levels afterwards to see how well the method works. This trial is a great opportunity to contribute to improving pain management techniques for future shoulder surgery patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • elective total or total reverse shoulder arthroplasty
- Exclusion Criteria:
- • inability to provide consent
- • history of active opioid use
- • emergency procedures
- • shoulder arthroscopy
- • partial shoulder replacement
- • shoulder resurfacing
- • any revision shoulder surgery
- • any indwelling deep brain stimulator, pacemaker, and/or other neurostimulators
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Jan Boublik, MD
Principal Investigator
Stanford University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials